Preserflo MicroShunt in refractory glaucoma: multicentre european results with up to three years of follow-up.

چکیده

To evaluate the real-world 3-year safety and efficacy of the Preserflo MicroShunt with mitomycin-C(MMC) in reducing intraocular pressure(IOP) and medications in patients with inadequately controlled glaucoma. This retrospective, multicentre, open-label study included consecutive patients who…

متن کامل چکیده در سایت ناشر در دسترس است.

موضوعات مرتبط

• لنز داخل چشمی
• گلوکوم (آب سیاه)